Skip to main content
Signal8

Shah Amit B.

SEC insider (Form 3/4/5 filer). CIK 0001719077. CFO at Oncotelic Therapeutics, Inc. (OTLC). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 10, 2026. Located in AGOURA HILLS, CA.

Companies Shah Amit B. has filed insider reports for

  • Oncotelic Therapeutics, Inc. (OTLC): Officer, CFO
Shah Amit B. profile photo

Shah Amit B.

CIK: 0001719077

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Oncotelic Therapeutics, Inc. logo
OTLC

Oncotelic Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Oncotelic Therapeutics, Inc. logo
    OTLC

    Oncotelic Therapeutics, Inc.

    Jul 10, 2026
    Award

    Restricted stock Units

    Direct
    1.5K shares-
  • Oncotelic Therapeutics, Inc. logo
    OTLC

    Oncotelic Therapeutics, Inc.

    Jun 22, 2026
    Purchase
    Direct
    20K shares at avg. $0.05$1K

1-2 of 2